A Cleveland Clinic spinout will give surgeons a “GPS-like” tool to navigate a patient’s insides while they’re on the operating table, so as to improve the efficacy and safeness of a surgical procedure. The startup, called Centerline Biomedical, will reduce radiation exposure, to boot.
Endovascular surgeons, for instance, traditionally use X-ray technology to guide their instruments and devices into position, the Cleveland Clinic says. This takes several hours, which exposes the patient – and the health workers – to a lot of potentially harmful radiation. X-rays also only give a two dimensional view of a patient’s insides – which makes navigation and positioning tough in a three-dimensional scenario.
“The concept came out of pure necessity,” Matthew Eagleton, a physician Cleveland Clinic’s Heart & Vascular Institute, said in a statement. “The combination of unsafe radiation levels, lengthy procedure times, and limited visualization capacity created an urgent opportunity to solve a real problem for hospitals and patients everywhere.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This is the 71st spinout from Cleveland Clinic, formed by its commercialization arm – Cleveland Clinic Innovations. It has gotten investment dollars from the Ohio BioValidation Fund, which is a state-supported early stage venture fund. William Fuller, the former CEO-in-residence of Cleveland’s BioEnterprise life sciences accelerator, was named Centerline’s CEO.